Skip to main content

Please wait ...

Richard Y. Cheng


Weaver Johnston Nelson, PLLC

Richard Y. Cheng’s practice focuses on corporate transactions, regulatory, compliance matters, and administrative appeals. His health care law practice includes representation of postacute care providers (e.g., nursing facilities, assisted living communities, continuing care retirement communities, home health care agencies, hospices, rehabilitation providers), community hospitals, management service organizations (MSOs), private equity groups and investors in health care, physician groups, ancillary providers (e.g., pharmacies, durable medical equipment companies, labs), retail medicine providers (e.g., urgent care centers, ambulatory surgery centers, emergency rooms), dental service organizations (DSOs), behavioral health, chiropractors, and veterinary practices.

Richard has considerable experience representing clients involving the Stark Law, the Anti-Kickback Statute, the False Claims Act, the Eliminating Kickbacks in Recovery Act, HIPAA, the HITECH Act, the Civil Monetary Penalties Law, state-based health care regulations, Medicare-related transactions (e.g., change of ownership), licensure surveys, the formation of MSOs and DSOs, managed care organization payment matters, Medicaid contracting, and Medicare appeals before administrative law judges.

Prior to joining Weaver Johnston Nelson, Richard was an equity partner and a member of the health care sector at one of the largest AmLaw 100 global firms. During his tenure, he launched the firm’s hemp/hemp products practice group, where he led multiple initiatives in building the firm’s reputation in cannabis. In addition, Richard formerly served as vice president and general counsel at two separate health care companies, where he assisted with change-of-ownership transactions, counseled on health care operational matters, and worked closely with outside counsel managing multiple litigation matters. He also created the medical appeals departments at both health care organizations, overseeing multiple staff members whom he trained, resulting in the successful recovery of millions of dollars in governmental and private health care insurance claims. Early in his career, Richard worked as a licensed occupational therapist; served as an adjunct faculty at multiple universities; and lobbied in Washington, D.C., through the American Occupational Therapy Association

In addition to his traditional health care practice, Richard developed a cannabis regulatory and corporate practice in 2013. As a leading cannabis attorney, Richard served as outside general counsel to the Texas Cannabis Industry Association, coauthored an FDA primer in preparation for the 2019 FDA public hearing on CBD products and has been named a top 250 cannabis legal expert by Databird Research Journal. He represents a broad base of cannabis-related clients, including private equity groups investing in the cannabis industry, physicians, medical marijuana dispensaries, seed developers, cultivators, processors, wholesalers, retailers, distribution centers, and ancillary providers (e.g., testing labs, biomass brokerage firms) and marketers.

Product Type
On Demand

Hemp: USDA Interim Final Rule and What it Means for Hemp Clients

Average Rating:
Hemp Law |  Regulation law |  Hemp
Shawn Hauser |  Alex Berger |  Richard Y. Cheng |  Mai T. Dinh
60 minutes
Audio and Video
Access for 6 month(s) after purchase.
Short Description:
This panel seeks to get to the bottom of the IFR and what it means for the hemp CBD industry currently and in the future. We may also touch on the intersection of USDA and FDA authority to regulate h...
$75.00 - Non Member Price

Showing 1 to 1 of 1 entries